https://dermfield.com/articles/mirdametinib-responses-deepen-through-year-4-in-reneu-long-term-data Derm Field en 2026-11-14T18:44:42.449Z Mirdametinib Responses Deepen Through Year 4 in ReNeu Long-Term Data https://dermfield.com/articles/roflumilast-cream-cut-infant-ad-itch-within-10-minutes-in-integument-infant Derm Field en 2026-11-14T05:34:41.781Z Roflumilast Cream Cut Infant AD Itch Within 10 Minutes in INTEGUMENT-INFANT https://dermfield.com/articles/type-2-inflammation-links-ad-prurigo-urticaria-and-bp-in-case-roundtable Derm Field en 2026-11-14T02:44:43.275Z Type 2 Inflammation Links AD, Prurigo, Urticaria and BP in Case Roundtable https://dermfield.com/articles/tebentafusp-doubles-5-year-survival-but-hla-negative-patients-still-wait Derm Field en 2026-11-14T01:34:44.085Z Tebentafusp Doubles 5-Year Survival, but HLA-Negative Patients Still Wait https://dermfield.com/articles/oral-icotrokinra-reaches-54-pasi-100-a-first-for-a-psoriasis-pill Derm Field en 2026-11-14T00:44:41.706Z Oral Icotrokinra Reaches 54% PASI 100, a First for a Psoriasis Pill https://dermfield.com/articles/cosibelimab-shows-sustained-results-in-advanced-cscc-at-2-5-years Derm Field en 2026-11-13T23:14:39.752Z Cosibelimab Shows Sustained Results in Advanced CSCC at 2.5 Years https://dermfield.com/articles/ghk-cu-boosts-collagen-at-picomolar-doses-but-nobody-has-tested-the-microbiome Derm Field en 2026-11-13T23:04:39.674Z GHK-Cu Boosts Collagen at Picomolar Doses — But Nobody Has Tested the Microbiome https://dermfield.com/articles/dermatologists-lead-gen-z-skin-care-trust-curology-survey-finds Derm Field en 2026-11-13T22:59:45.115Z Dermatologists lead Gen Z skin-care trust, Curology survey finds https://dermfield.com/articles/two-year-interpath-001-data-favor-personalized-mrna-therapy Derm Field en 2026-11-13T22:54:40.563Z Two-Year INTerpath-001 Data Favor Personalized mRNA Therapy https://dermfield.com/articles/jbs-buys-flora-for-us-542-million-entering-personal-care Derm Field en 2026-11-13T19:59:39.323Z JBS Buys Flora for US$542 Million, Entering Personal Care https://dermfield.com/articles/omalizumab-biosimilar-shows-qol-gains-in-csu-phase-3-post-hoc-data Derm Field en 2026-11-13T08:09:37.278Z Omalizumab Biosimilar Shows QoL Gains in CSU Phase 3 Post Hoc Data https://dermfield.com/articles/80-4-nf1-risk-in-toddlers-with-six-or-more-cafe-au-lait-macules Derm Field en 2026-11-13T06:44:37.368Z 80.4% NF1 Risk in Toddlers With Six or More Café-au-Lait Macules https://dermfield.com/articles/personalized-cancer-vaccine-succeeds-in-phase-3-melanoma-trial Derm Field en 2026-11-13T02:29:37.325Z Personalized Cancer Vaccine Succeeds in Phase 3 Melanoma Trial https://dermfield.com/articles/remind-trial-how-remibrutinib-25-mg-twice-daily-was-measured-in-cindu Derm Field en 2026-11-13T02:24:37.185Z REMIND Trial: How Remibrutinib 25 mg Twice Daily Was Measured in CIndU https://dermfield.com/articles/experts-urge-nuanced-choice-between-vismodegib-and-sonidegib-in-advanced-bcc Derm Field en 2026-11-13T02:14:37.000Z Experts Urge Nuanced Choice Between Vismodegib and Sonidegib in Advanced BCC https://dermfield.com/articles/risankizumab-hits-pasi-100-in-41-of-adolescents-in-optimmize-1 Derm Field en 2026-11-13T01:24:38.953Z Risankizumab Hits PASI 100 in 41% of Adolescents in OptIMMize-1 https://dermfield.com/articles/dermatology-approvals-and-pipeline-advances Derm Field en 2026-11-13T00:49:36.969Z October 2026 dermatology approvals and pipeline advances https://dermfield.com/articles/eight-eastman-pet-resins-receive-recyclass-approval Derm Field en 2026-11-13T00:09:37.321Z Eight Eastman PET resins receive RecyClass approval https://dermfield.com/articles/k-beauty-hit-15bn-online-but-is-the-boom-peaking Derm Field en 2026-11-12T21:24:36.786Z K-Beauty Hit $15bn Online in 2025 — But Is the Boom Peaking? https://dermfield.com/articles/l-oreal-leads-investment-in-chinese-ai-biotech-pam2l Derm Field en 2026-11-12T21:19:38.517Z L'Oréal Leads Investment in Chinese AI Biotech PAM2L https://dermfield.com/articles/microcrack-coating-kills-80-of-bacteria-with-one-9-volt-pulse Derm Field en 2026-11-12T20:39:38.756Z Microcrack Coating Kills 80% of Bacteria With One 9-Volt Pulse